Protecting against Lenacapavir misinformation with young women in Gauteng, South Africa (PROTECT-L)

Organization: Health Economics and Epidemiology Research Office (HE2RO)

 

 

Study objective: To compare changes in intentions to receive LEN following misinformation exposure in groups with and without psychological inoculation and behavioural economics boost.

 

 

Intervention & evaluation description:

Formative work: We will conduct a ranking survey to identify the most concerning misinformation claims among young women. Using results from this survey, we will co-design inoculation messages with young women that will be tested in the randomised controlled trial. 

 

Randomised controlled trial of inoculation messages: This will be a two-arm RCT of psychological inoculation messages designed to counter misinformation about LEN.

 

  • Intervention group: Participants will receive  inoculation messages in video format that warns about misinformation and pre-bunk false LEN claims
  • Attention control group: Participants will view health information videos unrelated to LEN, of the same length and format as the inoculation videos.

 

All participants will:

  • Complete a post-intervention survey
  • Receive a debriefing statement which clarifies that the misinformation they were exposed to was false
  • May be invited to complete a follow-up survey after 2-6 weeks to measure persistence of intervention effects

 

 

Study outcomes:

Primary Outcome:

  • Intention to receive LEN following exposure to misinformation

 

Secondary Outcomes:

  • Intention to receive LEN 2-6 weeks following the exposure
  • Believability and persuasiveness of misinformation
  • Interest in sharing misinformation and motivational threat associated with misinformation
  • Subgroup effects by relevant sociodemographic and behavioural factors

 

 

Study site: The study will be conducted in Gauteng, South Africa.

 

 

Target population:

Formative work

Inclusion criteria:

  • Female, aged 18–29 years
  • Able to read and understand English
  • Willing and able to provide informed consent

 

Exclusion criteria:

  • Unwilling or unable to provide consent
  • Unavailable to complete study procedures

 

Randomised controlled trial of inoculation messages

Inclusion criteria:

  • Female (cisgender or transgender)
  • Age 18-29 years
  • Self-reported history of sexual activity in the past 12 months
  • Self-reported HIV-negative status or unknown HIV status at enrolment
  • Willing and able to provide consent
  • Able to read and understand English

 

Exclusion criteria:

  • Unwilling or unable to provide consent for study participation

 

 

Study population:

For the formative work: we will enroll up to 1,000 young women from the B-Hub. 

For the RCT: we will enroll about 1500 young women in the study.

 

 

Duration: 18 months